BDX Q4 2021 Earnings — Becton, Dickinson and Company Revenue & Financial Results | Market Cap Arena

BDXBecton, Dickinson and Company

$60B

Q4 2021 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$5.1B+7.3% YoY

Gross Profit

$2.3B44.5% margin

Operating Income

$495M9.6% margin

Net Income

$265M5.2% margin

EPS (Diluted)

$0.84

QoQ Revenue Growth

+11.5%

Cash Flow

Operating Cash Flow

$951M

Free Cash Flow

$486M

Stock-Based Comp.

$48M

Balance Sheet

Total Assets

$53.9B

Total Liabilities

$30.2B

Stockholders' Equity

$23.7B

Cash & Equivalents

$2.3B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5.1B	$4.8B	+7.3%
Gross Profit	$2.3B	$2.2B	+3.7%
Operating Income	$495M	$255M	+94.1%
Net Income	$265M	$128M	+107.0%

Revenue Segments

Medical

$2.5B49%

Life Sciences

$1.5B30%

Interventional

$1.1B21%

Geographic Segments

UNITED STATES

$2.8B55%

Non-US

$2.3B45%